Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma

Immunotherapy

Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors

Eur J Cancer

Makarious D, Horwood K, Coward JIG

doi: 10.1016/j.ejca.2017.05.041.

Melanoma and Skin CancerT Cells

Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade

Br J Dermatol.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC

doi: 10.1111/bjd.18379.

T Cells

Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer

J Autoimmun

Calabrese LH, Caporali R, Blank CU, Kirk AD

doi: 10.1016/j.jaut.2020.102546

ImmunotherapyT Cells

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy

Front Immunol.

Guram K, Kim SS, Wu V, Sanders PD, Patel S, Schoenberger SP, Cohen EEW, Chen SY, Sharabi AB

doi: 10.3389/fimmu.2019.00491.

COMMENTED

Immunotherapy

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

★ 3 Recommended and commented by Prof. Dr Dr Sacha Rothschild, Faculty Member

Eur J Cancer

Ghisoni E, Wicky A, Bouchaab H, Imbimbo M, Delyon J, Gautron Moura B, Gérard CL, Latifyan S, Özdemir BC, Caikovski M, Pradervand S, Tavazzi E, Gatta R, Marandino L, Valabrega G, Aglietta M, Obeid M, Homicsko K, Mederos Alfonso NN, Zimmermann S, Coukos G, Peters S, Cuendet MA, Di Maio M, Michielin O

doi: 10.1016/j.ejca.2021.03.010

Immune Response

How to dissect the plasticity of antigen specific immune response: A tissue perspective

Clin Exp Immunol.

Amodio D, Santilli V, Zangari P, Cotugno N, Manno EC, Rocca S, Rossi P, Cancrini C, Finocchi A, Chassiakos A, Petrovas C, Palma P

doi: 10.1111/cei.13386.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding

Rheumatology (Oxford).

Daoussis D, Kraniotis P, Filippopoulou A, Argiriadi R, Theodoraki S, Makatsoris T, Koutras A, Kehagias I, Papachristou DJ, Solomou A, Kalofonos H, Liossis SN

doi: 10.1093/rheumatology/kez361.

The tumour glyco-code as a novel immune checkpoint for immunotherapy

Nat Rev Immunol.2018 Mar;18(3):204-211.doi: 10.1038/nri.2018.3.

RodrÍguez E, Schetters STT, van Kooyk Y

doi: 10.1038/nri.2018.3.